vs
Side-by-side financial comparison of LGL GROUP INC (LGL) and Varex Imaging Corp (VREX). Click either name above to swap in a different company.
Varex Imaging Corp is the larger business by last-quarter revenue ($209.6M vs $803.0K, roughly 261.0× LGL GROUP INC). Varex Imaging Corp runs the higher net margin — 1.1% vs -3.4%, a 4.5% gap on every dollar of revenue. On growth, LGL GROUP INC posted the faster year-over-year revenue change (23.0% vs 4.9%). Over the past eight quarters, LGL GROUP INC's revenue compounded faster (43.1% CAGR vs 0.8%).
LGL Group Inc is a global electronic components manufacturer that designs, produces and markets high-performance frequency control products, radio frequency components and integrated circuit solutions. It primarily serves aerospace, defense, telecommunications, industrial and medical technology end markets, supplying specialized parts with strict reliability requirements.
Varex Imaging Corp is a global supplier of advanced imaging components and solutions, including X-ray tubes, digital flat panel detectors, and image processing software. Its products serve medical imaging, radiation oncology, and industrial non-destructive testing segments, with customers across key global markets.
LGL vs VREX — Head-to-Head
Income Statement — Q4 2025 vs Q1 2026
| Metric | | |
|---|---|---|
| Revenue | $803.0K | $209.6M |
| Net Profit | $-27.0K | $2.3M |
| Gross Margin | — | 33.3% |
| Operating Margin | 14.8% | 7.3% |
| Net Margin | -3.4% | 1.1% |
| Revenue YoY | 23.0% | 4.9% |
| Net Profit YoY | -113.4% | 866.7% |
| EPS (diluted) | $-0.02 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $209.6M | ||
| Q4 25 | $803.0K | $228.9M | ||
| Q3 25 | $661.0K | $203.0M | ||
| Q2 25 | $491.0K | $212.9M | ||
| Q1 25 | $498.0K | $199.8M | ||
| Q4 24 | $653.0K | — | ||
| Q3 24 | $650.0K | $205.7M | ||
| Q2 24 | $531.0K | $209.1M |
| Q1 26 | — | $2.3M | ||
| Q4 25 | $-27.0K | $12.2M | ||
| Q3 25 | $772.0K | $-89.1M | ||
| Q2 25 | $-51.0K | $6.9M | ||
| Q1 25 | $-6.0K | $-300.0K | ||
| Q4 24 | $202.0K | — | ||
| Q3 24 | $72.0K | $-51.1M | ||
| Q2 24 | $137.0K | $1.4M |
| Q1 26 | — | 33.3% | ||
| Q4 25 | — | 34.0% | ||
| Q3 25 | — | 33.3% | ||
| Q2 25 | — | 36.0% | ||
| Q1 25 | — | 34.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 32.6% | ||
| Q2 24 | — | 32.0% |
| Q1 26 | — | 7.3% | ||
| Q4 25 | 14.8% | 8.6% | ||
| Q3 25 | 18.2% | -39.8% | ||
| Q2 25 | -6.3% | 10.4% | ||
| Q1 25 | 8.2% | 5.6% | ||
| Q4 24 | 37.5% | — | ||
| Q3 24 | 21.2% | 5.3% | ||
| Q2 24 | 44.6% | 4.4% |
| Q1 26 | — | 1.1% | ||
| Q4 25 | -3.4% | 5.3% | ||
| Q3 25 | 116.8% | -43.9% | ||
| Q2 25 | -10.4% | 3.2% | ||
| Q1 25 | -1.2% | -0.2% | ||
| Q4 24 | 30.9% | — | ||
| Q3 24 | 11.1% | -24.8% | ||
| Q2 24 | 25.8% | 0.7% |
| Q1 26 | — | $0.05 | ||
| Q4 25 | $-0.02 | $0.29 | ||
| Q3 25 | $0.14 | $-2.15 | ||
| Q2 25 | $-0.01 | $0.17 | ||
| Q1 25 | $0.00 | $-0.01 | ||
| Q4 24 | $0.05 | — | ||
| Q3 24 | $0.01 | $-1.25 | ||
| Q2 24 | $0.02 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $41.5M | $125.6M |
| Total DebtLower is stronger | — | $367.6M |
| Stockholders' EquityBook value | $43.5M | $476.9M |
| Total Assets | $46.8M | $1.1B |
| Debt / EquityLower = less leverage | — | 0.77× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $125.6M | ||
| Q4 25 | $41.5M | $155.1M | ||
| Q3 25 | $41.6M | $152.6M | ||
| Q2 25 | $41.8M | $223.0M | ||
| Q1 25 | $41.9M | $212.6M | ||
| Q4 24 | $41.6M | — | ||
| Q3 24 | $41.6M | $200.5M | ||
| Q2 24 | $41.1M | $190.0M |
| Q1 26 | — | $367.6M | ||
| Q4 25 | — | $367.5M | ||
| Q3 25 | — | $367.5M | ||
| Q2 25 | — | $567.2M | ||
| Q1 25 | — | $567.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $443.4M | ||
| Q2 24 | — | $443.1M |
| Q1 26 | — | $476.9M | ||
| Q4 25 | $43.5M | $472.6M | ||
| Q3 25 | $39.8M | $455.3M | ||
| Q2 25 | $39.1M | $549.7M | ||
| Q1 25 | $39.2M | $540.2M | ||
| Q4 24 | $39.2M | — | ||
| Q3 24 | $39.0M | $529.1M | ||
| Q2 24 | $38.9M | $581.2M |
| Q1 26 | — | $1.1B | ||
| Q4 25 | $46.8M | $1.1B | ||
| Q3 25 | $43.3M | $1.1B | ||
| Q2 25 | $43.0M | $1.4B | ||
| Q1 25 | $43.3M | $1.3B | ||
| Q4 24 | $43.1M | — | ||
| Q3 24 | $42.5M | $1.2B | ||
| Q2 24 | $42.2M | $1.3B |
| Q1 26 | — | 0.77× | ||
| Q4 25 | — | 0.78× | ||
| Q3 25 | — | 0.81× | ||
| Q2 25 | — | 1.03× | ||
| Q1 25 | — | 1.05× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.84× | ||
| Q2 24 | — | 0.76× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-355.0K | $-16.1M |
| Free Cash FlowOCF − Capex | — | $-26.8M |
| FCF MarginFCF / Revenue | — | -12.8% |
| Capex IntensityCapex / Revenue | — | 5.1% |
| Cash ConversionOCF / Net Profit | — | -7.00× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-13.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $-16.1M | ||
| Q4 25 | $-355.0K | $7.9M | ||
| Q3 25 | $275.0K | $7.7M | ||
| Q2 25 | $-190.0K | $16.6M | ||
| Q1 25 | $340.0K | $9.5M | ||
| Q4 24 | $-17.0K | — | ||
| Q3 24 | $528.0K | $25.9M | ||
| Q2 24 | $203.0K | $8.0M |
| Q1 26 | — | $-26.8M | ||
| Q4 25 | — | $2.3M | ||
| Q3 25 | — | $1.4M | ||
| Q2 25 | — | $9.8M | ||
| Q1 25 | — | $5.3M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $19.9M | ||
| Q2 24 | — | $3.3M |
| Q1 26 | — | -12.8% | ||
| Q4 25 | — | 1.0% | ||
| Q3 25 | — | 0.7% | ||
| Q2 25 | — | 4.6% | ||
| Q1 25 | — | 2.7% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 9.7% | ||
| Q2 24 | — | 1.6% |
| Q1 26 | — | 5.1% | ||
| Q4 25 | — | 2.4% | ||
| Q3 25 | — | 3.1% | ||
| Q2 25 | — | 3.2% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.9% | ||
| Q2 24 | — | 2.2% |
| Q1 26 | — | -7.00× | ||
| Q4 25 | — | 0.65× | ||
| Q3 25 | 0.36× | — | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | — | ||
| Q4 24 | -0.08× | — | ||
| Q3 24 | 7.33× | — | ||
| Q2 24 | 1.48× | 5.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LGL
Segment breakdown not available.
VREX
| Medical Segment | $144.8M | 69% |
| Industrial Segment | $64.8M | 31% |
